Format
Sort by

Send to:

Choose Destination

Search results

Items: 5

1.

Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database.

Soranna D, Bosetti C, Casula M, Tragni E, Catapano AL, Vecchia CL, Merlino L, Corrao G.

Diabetes Res Clin Pract. 2015 May;108(2):243-9. doi: 10.1016/j.diabres.2015.02.013. Epub 2015 Feb 23.

PMID:
25748827
2.

Are generic and brand-name statins clinically equivalent? Evidence from a real data-base.

Corrao G, Soranna D, Arfè A, Casula M, Tragni E, Merlino L, Mancia G, Catapano AL.

Eur J Intern Med. 2014 Oct;25(8):745-50. doi: 10.1016/j.ejim.2014.08.002. Epub 2014 Sep 6.

PMID:
25200803
3.

Statins and the risk of diabetes: evidence from a large population-based cohort study.

Corrao G, Ibrahim B, Nicotra F, Soranna D, Merlino L, Catapano AL, Tragni E, Casula M, Grassi G, Mancia G.

Diabetes Care. 2014 Aug;37(8):2225-32. doi: 10.2337/dc13-2215. Epub 2014 Jun 26.

PMID:
24969582
4.

High-potency statins increase the risk of acute kidney injury: evidence from a large population-based study.

Corrao G, Soranna D, Casula M, Merlino L, Porcellini MG, Catapano AL.

Atherosclerosis. 2014 May;234(1):224-9. doi: 10.1016/j.atherosclerosis.2014.02.022. Epub 2014 Mar 15.

PMID:
24681912
5.

Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected].

Casula M, Soranna D, Catapano AL, Corrao G.

Atheroscler Suppl. 2013 Aug;14(2):243-51. doi: 10.1016/S1567-5688(13)70005-9. Review. Erratum in: Atheroscler Suppl. 2014 Mar;233(1):122.

PMID:
23958480
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk